Search Results - "Wilf‐Yarkoni, Adi"

Investigation of cardiac arrhythmia events in patients treated with lamotrigine: FDA adverse event reporing system analysis by Aboukaoud, Mohammed, Wilf-Yarkoni, Adi, Maor, Elad

“…In October 2020 and March 2021, the U.S. Food and Drug Administration (FDA) classified lamotrigine as a class IB antiarrhythmic, announcing an increased risk…”
Get full text

Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel by Lotan, Itay, Wilf‐Yarkoni, Adi, Friedman, Yitzhak, Stiebel‐Kalish, Hadas, Steiner, Israel, Hellmann, Mark A.

“…Background and purpose Although the COVID‐19 vaccines are currently recommended for people with multiple sclerosis (MS), the fact that they were not…”
Get full text

Age-dependent effects of chronic stress on brain plasticity and depressive behavior by Toth, Erika, Gersner, Roman, Wilf-Yarkoni, Adi, Raizel, Hagit, Dar, Dalit E, Richter-Levin, Gal, Levit, Ofir, Zangen, Abraham

“…Exposure to chronic mild stress (CMS) is known to induce anhedonia in adult animals, and is associated with induction of depression in humans. However, the…”
Get full text

The effect of COVID‐19 vaccination on multiple sclerosis activity as reflected by MRI by Ganelin‐Cohen, Esther, Buxbaum, Chen, Bosak, Noam, Sobol, Shani, Vaknin‐Dembinsky, Adi, Hellmann, Mark A, Wilf‐Yarkoni, Adi, Regev, Keren, Pustovoyt, Elizaveta, Shifrin, Alla, Wexler, Yair, Rozenberg, Ayal

“…Introduction Examining the safety of theBNT162b2 mRNA vaccine in multiple sclerosis (MS) patients remains inconclusive, particularly regarding the potential…”
Get full text

Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review by Lotan, Itay, Hellmann, Mark A., Wilf-Yarkoni, Adi, Steiner, Israel

“…Corticosteroids (CS) are among the most widely- used immunosuppressive agents for immune-mediated conditions, including myasthenia gravis (MG). While their…”
Get full text

Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis by Wilf-Yarkoni, Adi, Lotan, Itay, Steiner, Israel, Hellmann, Mark A.

“…Introduction Intravenous immunoglobulin (IVIg) has been proven beneficial in myasthenic crisis, but their role as maintenance therapy is unclear. The aim of…”
Get full text

Susac’s syndrome – A new ocular finding and disease outcome by Dinah Zur, Michaella Goldstein, Barequet, Dana, Oron, Yahav, Elkayam, Ori, Karni, Arnon, Wilf-Yarkoni, Adi, Regev, Keren, Habot-Wilner, Zohar

“…Background Susac’s syndrome, a rare autoimmune vasculo-occlusive disease, may pose a diagnostic challenge and result in a devastating ocular and systemic…”
Get full text

Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis by Wilf-Yarkoni, Adi, Feldmann, Kristina, Rubarth, Kerstin, Dorsch, Eva-Maria, Rust, Rebekka, Urman, Ilia, Hellmann, Mark A, Friedman, Yitzhak, Lotan, Itay, Bialer, Omer, Buenrostro, Gilberto Solorza, Zimmermann, Hanna G, Leutloff, Carla, Schmitz-Hübsch, Tanja, Paul, Friedemann, Asseyer, Susanna, Stiebel-Kalish, Hadas

“…Acute optic neuritis treatment lacks standardized protocols. The value of oral prednisone taper (OPT) following intravenous methylprednisolone (IVMP) on visual…”
Get full text

Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease by Lotan, Itay, Chen, John J, Hacohen, Yael, Abdel-Mannan, Omar, Mariotto, Sara, Huda, Saif, Gibbons, Emily, Wilf-Yarkoni, Adi, Hellmann, Mark A, Stiebel-Kalish, Hadas, Pittock, Sean J, Flanagan, Eoin P, Molazadeh, Negar, Anderson, Monique, Salky, Rebecca, Romanow, Gabriela, Schindler, Patrick, Duchow, Ankelien Solveig, Paul, Friedemann, Levy, Michael

“…Background: The potential therapeutic benefit of intravenous immunoglobulins (IVIGs) for acute attacks of myelin oligodendrocyte glycoprotein antibody disease…”
Get full text

Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis by Stiebel-Kalish, Hadas, Rubarth, Kerstin, Shouchane-Blum, Karny, Tiosano, Alon, Lotan, Itay, Hellmann, Mark A., Wilf-Yarkoni, Adi, Bialer, Omer, Flanagan, Eoin P., Pittock, Sean J., Bhatti, M. Tariq, Schmitz-Hübsch, Tanja, Paul, Friedemann, Asseyer, Susanna, Chen, John J.

“…Optic neuritis (ON) is a frequent presentation at onset of multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte…”
Get full text

Author Correction: Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis by Stiebel-Kalish, Hadas, Rubarth, Kerstin, Shouchane-Blum, Karny, Tiosano, Alon, Lotan, Itay, Hellmann, Mark A., Wilf-Yarkoni, Adi, Bialer, Omer, Flanagan, Eoin P., Pittock, Sean J., Bhatti, M. Tariq, Schmitz-Hübsch, Tanja, Paul, Friedemann, Asseyer, Susanna, Chen, John J.

Get full text

Details and outcomes of a large cohort of MOG-IgG associated optic neuritis by Chen, John J., Flanagan, Eoin P., Bhatti, M. Tariq, Tisavipat, Nanthaya, Jamali, Sepideh, Kunchok, Amy, Eggenberger, Eric R., Nome, Marie Di, Sotirchos, Elias S., Vasileiou, Eleni S., Henderson, Amanda D., Arnold, Anthony C., Bonelli, Laura, Seleme, Nicolas, Mejia-Vergara, Alvaro J., Moss, Heather E., Padungkiatsagul, Tanyatuth, Stiebel-Kalish, Hadas, Lotan, Itay, Wilf-Yarkoni, Adi, Hellmann, Mark A., Vuppala, Amrita, Hodge, David, Pittock, Sean J.

“…•Eye pain was present in 89% of optic neurits attacks from MOG-IgG associated disease (MOGAD) and often precedes the vision loss.•Early intravenous…”
Get full text

Repeated lumbar puncture in search of oligoclonal bands – What is the yield? by Mermelstein, Maor, Naftali, Jonathan, Wilf-Yarkoni, Adi, Lotan, Itay, Hellmann, Mark Andrew, Steiner, Israel

“…Cerebrospinal fluid (CSF) oligoclonal bands (OCBs) are immunoglobulins that represent intrathecal synthesis during central nervous system infection or…”
Get full text

Expanding the spectrum of white matter abnormalities in Wolfram syndrome: A retrospective review of six cases by Simo, Justin, Ashton, Catherine, Ito, Shoichi, Wilf-Yarkoni, Adi, Goldberg, Yael, Cocozza, Sirio, Rouleau, Guy, Nadjar, Yann, La Piana, Roberta

Get full text

Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis by Lotan, Itay, Hellmann, Mark A., Friedman, Yitzhak, Stiebel-Kalish, Hadas, Steiner, Israel, Wilf-Yarkoni, Adi

“…•The safety and tolerability profile of the COVID-19 vaccines in MG is currently unknown.•The rate of adverse events in our survey was similar to that reported…”
Get full text

Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group‏ Viewpoint by Petrou, Panayiota, Achiron, Anat, Cohen, Esther Ganelin, Garty, Maya, Magalashvili, David, Karmon, Yuval, Milo, Ron, Regev, Keren, Vaknin-Dembinsky, Adi, Wilf-Yarkoni, Adi, Karussis, Dimitrios

“…Cladribine tablets (Mavenclad ® ) were approved by the European Union in 2017 as high-efficacy therapy for highly active relapsing–remitting multiple…”
Get full text

Association between clinical characteristics, acute steroid treatment and oligoclonal bands result in multiple sclerosis: A retrospective study by Tolkovsky, Assaf, Pardo, Keshet, Hellmann, Mark, Lotan, Itay, Auriel, Eitan, Wilf-Yarkoni, Adi

“…•Various factors may affect oligoclonal bands detection in the cerebrospinal fluid.•Steroid treatment before lumber puncture did not affect oligoclonal bands…”
Get full text

Long-term Outcomes of MOGAD without Chronic Steroid-sparing Immunotherapy: a Multicenter Retrospective Cohort (S40.008) by Tisavipat, Nanthaya, Wilf-Yarkoni, Adi, Flanagan, Eoin, Redenbaugh, Vyanka, Schwartzmann, Yoel, Hellmann, Mark, Tolkovsky, Assaf, Stiebel-Kalish, Hadas, Lotan, Itay, Levy, Michael, Salky, Rebecca, Vaknin-Dembinsky, Adi, Ganelin-Cohen, Esther, Lopez, Alfonso, Pittock, Sean, Chen, John

“…Abstract only…”
Get full text

Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease by Chen, John J, Huda, Saif, Hacohen, Yael, Levy, Michael, Lotan, Itay, Wilf-Yarkoni, Adi, Stiebel-Kalish, Hadas, Hellmann, Mark A, Sotirchos, Elias S, Henderson, Amanda D, Pittock, Sean J, Bhatti, M Tariq, Eggenberger, Eric R, Di Nome, Marie, Kim, Ho Jin, Kim, Su-Hyun, Saiz, Albert, Paul, Friedemann, Dale, Russell C, Ramanathan, Sudarshini, Palace, Jacqueline, Camera, Valentina, Leite, Maria Isabel, Lam, Byron L, Bennett, Jeffrey L, Mariotto, Sara, Hodge, Dave, Audoin, Bertrand, Maillart, Elisabeth, Deschamps, Romain, Pique, Julie, Flanagan, Eoin P, Marignier, Romain

“…Recent studies suggest that maintenance intravenous immunoglobulin (IVIG) may be an effective treatment to prevent relapses in myelin oligodendrocyte…”
Get more information

Applicability of the New Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Diagnostic Criteria in an Israeli Cohort by Fineberg, Aviv, Lotan, Itay, Bialer, Omer, Tiosano, Alon, Rozenblatt, Shira, Wilf-Yarkoni, Adi, Hellmann, Mark A, Stiebel-Kalish, Hadas

“…Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune demyelinating disorder of the central nervous system. Optic…”
Get full text